HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
FRIDAY, Sept. 21, 2018 (HealthDay News) -- Malaria is transmitted by mosquitoes carrying malaria parasites, but scientists report they have discovered compounds that might keep mosquitoes from spreading the sometimes deadly disease.
"Current anti-malarial drugs can cure a person of the disease, but that person is still infectious to mosquitoes, and can therefore still cause someone else to become infected," explained lead researcher Jake Baum, of the department of life sciences at Imperial College London.
"What we propose is anti-malarial drugs that protect mosquitoes, blocking the parasites from continuing their infectious journey," Baum said in a college news release. "By combining such a drug with a conventional anti-malarial, we not only cure the individual person, but protect the community as well."
People who get malaria usually develop high fevers, chills and flu-like symptoms. The disease claims nearly 450,000 lives around the world each year, according to the U.S. Centers for Disease Control and Prevention.
People diagnosed with the disease can be treated with drugs that destroy the replicating form of the parasite, but dormant sexual forms may remain, the researchers explained.
These dormant parasites can be transmitted to mosquitoes that bite infected people. Once transferred, these dormant parasites mature, multiply and gather in the mosquito's salivary glands where they are ready to infect others who are bitten by the insect.
But the researchers identified compounds that could stop the spread of malaria by making malaria parasites incapable of infecting mosquitoes. After screening more than 70,000 compounds, the team pinpointed six with the potential to become malaria-blocking drugs.
Once in mosquitoes, sexual malaria parasites are very active, which makes them ideal drug targets. To identify compounds that could interfere with these sexual parasites, the researchers tricked the parasites into replicating.
"Overall, we screened around 70,000 molecules and found only a handful of potent compounds that are both active and safe to use with human cells," Baum said. "It was like finding needles in a haystack."
The scientists are researching all the compounds to determine exactly how they work and how they could be developed into drugs that are stable enough to be given to person and survive being ultimately transferred to mosquitoes.
The findings were published Sept. 18 in the journal Nature Communications.
The U.S. Centers for Disease Control and Prevention has more about malaria.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.